KYOWA KIRIN CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
Kura Oncology Initiates Phase 1 Trial Combining Ziftomenib with Imatinib for Advanced GIST Treatment
Kura Oncology has dosed first patients in KOMET-015, a Phase 1 trial evaluating ziftomenib in combination with imatinib for advanced gastrointestinal stromal tumors (GIST) after imatinib failure.
Fasenra Approved in the EU for Eosinophilic Granulomatosis with Polyangiitis
AstraZeneca's Fasenra (benralizumab) has been approved in the EU for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA).